{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:58:45Z","timestamp":1793480325370,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26460969"],"award-info":[{"award-number":["26460969"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00535-016-1292-z","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T05:40:59Z","timestamp":1480398059000},"page":"904-919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation"],"prefix":"10.1007","volume":"52","author":[{"given":"Shoichiro","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Shinzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Iwatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tsujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Motooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"1292_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1136\/gut.2010.218180","volume":"60","author":"T Ochsenk\u00fchn","year":"2011","unstructured":"Ochsenk\u00fchn T, D\u2019Haens G. Current misunderstandings in the management of ulcerative colitis. Gut. 2011;60:1294\u20139.","journal-title":"Gut"},{"key":"1292_CR2","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","volume":"380","author":"D Laharie","year":"2012","unstructured":"Laharie D, Bourreille A, Branche J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012;380:1909\u201315.","journal-title":"Lancet"},{"key":"1292_CR3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/apt.12464","volume":"38","author":"SC Ng","year":"2013","unstructured":"Ng SC, Lam YT, Tsoi KK, et al. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:854\u201363.","journal-title":"Aliment Pharmacol Ther"},{"key":"1292_CR4","first-page":"210","volume":"28","author":"A Triantafyllidi","year":"2015","unstructured":"Triantafyllidi A, Xanthos T, Papalois A, et al. Herbal and plant therapy in patients with inflammatory bowel disease. Ann Gastroenterol. 2015;28:210\u201320.","journal-title":"Ann Gastroenterol"},{"key":"1292_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1055\/s-0029-1185447","volume":"75","author":"I Plitzko","year":"2009","unstructured":"Plitzko I, Mohn T, Sedlacek N, et al. Composition of Indigo naturalis. Planta Med. 2009;75:860\u20133.","journal-title":"Planta Med"},{"key":"1292_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/bjd.12557","volume":"169","author":"S Deng","year":"2013","unstructured":"Deng S, May BH, Zhang AL, et al. Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169:769\u201382.","journal-title":"Br J Dermatol"},{"key":"1292_CR7","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3748\/wjg.v19.i17.2718","volume":"19","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Kaneko T, Mizokami Y, et al. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol. 2013;19:2718\u201322.","journal-title":"World J Gastroenterol"},{"key":"1292_CR8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1440-1746.2012.07215.x","volume":"27","author":"K Fukunaga","year":"2012","unstructured":"Fukunaga K, Ohda Y, Hida N, et al. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. J Gastroenterol Hepatol. 2012;27:1808\u201315.","journal-title":"J Gastroenterol Hepatol"},{"key":"1292_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1089\/acm.2012.0296","volume":"19","author":"F Zhang","year":"2013","unstructured":"Zhang F, Li Y, Xu F, et al. Comparison of Xilei-san, a Chinese herbal medicine, and dexamethasone in mild\/moderate ulcerative proctitis: a double-blind randomized clinical trial. J Altern Complement Med. 2013;19:838\u201342.","journal-title":"J Altern Complement Med"},{"key":"1292_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000444217","volume":"93","author":"S Sugimoto","year":"2016","unstructured":"Sugimoto S, Naganuma M, Kiyohara H, et al. Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: a single-center open-label prospective study. Digestion. 2016;93:193\u2013201.","journal-title":"Digestion"},{"key":"1292_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00535-016-1220-2","volume":"51","author":"S Sugimoto","year":"2016","unstructured":"Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol. 2016;51:853\u201361.","journal-title":"J Gastroenterol"},{"key":"1292_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B, Di Meglio P, Gialitakis M, et al. The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol. 2014;32:403\u201332.","journal-title":"Annu Rev Immunol"},{"key":"1292_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00204-007-0232-3","volume":"82","author":"K Sugihara","year":"2008","unstructured":"Sugihara K, Okayama T, Kitamura S, et al. Comparative study of aryl hydrocarbon receptor ligand activities of six chemicals in vitro and in vivo. Arch Toxicol. 2008;82:5\u201311.","journal-title":"Arch Toxicol"},{"key":"1292_CR14","doi-asserted-by":"publisher","first-page":"31475","DOI":"10.1074\/jbc.C100238200","volume":"276","author":"J Adachi","year":"2001","unstructured":"Adachi J, Mori Y, Matsui S, et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem. 2001;276:31475\u20138.","journal-title":"J Biol Chem"},{"key":"1292_CR15","unstructured":"Monteleone I, Rizzo A, Sarra M, et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology. 2011;141:237\u201348, 248.e1."},{"key":"1292_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fimmu.2014.00551","volume":"5","author":"NT Nguyen","year":"2014","unstructured":"Nguyen NT, Nakahama T, Le DH, et al. Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol. 2014;5:551.","journal-title":"Front Immunol"},{"key":"1292_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00535-015-1112-x","volume":"51","author":"E Shiraishi","year":"2016","unstructured":"Shiraishi E, Iijima H, Shinzaki S, et al. Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis. J Gastroenterol. 2016;51:346\u201356.","journal-title":"J Gastroenterol"},{"key":"1292_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2011.09.025","volume":"147","author":"Y Li","year":"2011","unstructured":"Li Y, Innocentin S, Withers DR, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell. 2011;147:629\u201340.","journal-title":"Cell"},{"key":"1292_CR19","doi-asserted-by":"crossref","unstructured":"Shinzaki S, Ishii M, Fujii H, et al. N-acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis. J Gastroenterol. 2016;51:357\u201369.","DOI":"10.1007\/s00535-015-1119-3"},{"key":"1292_CR20","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1007\/s10620-011-1643-9","volume":"56","author":"K Furumatsu","year":"2011","unstructured":"Furumatsu K, Nishiumi S, Kawano Y, et al. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci. 2011;56:2532\u201344.","journal-title":"Dig Dis Sci"},{"key":"1292_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/intimm\/4.9.959","volume":"4","author":"WK Aicher","year":"1992","unstructured":"Aicher WK, Fujihashi K, Yamamoto M, et al. Effects of the lpr\/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site. Int Immunol. 1992;4:959\u201368.","journal-title":"Int Immunol"},{"key":"1292_CR22","doi-asserted-by":"publisher","first-page":"18174","DOI":"10.1038\/srep18174","volume":"5","author":"J Lee","year":"2015","unstructured":"Lee J, Park EJ, Yuki Y, et al. Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis. Sci Rep. 2015;5:18174.","journal-title":"Sci Rep"},{"key":"1292_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.gastro.2004.11.063","volume":"128","author":"T Dohi","year":"2005","unstructured":"Dohi T, Ejima C, Kato R, et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology. 2005;128:411\u201323.","journal-title":"Gastroenterology"},{"key":"1292_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1084\/jem.20030437","volume":"199","author":"H Iijima","year":"2004","unstructured":"Iijima H, Neurath MF, Nagaishi T, et al. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med. 2004;199:471\u201382.","journal-title":"J Exp Med"},{"key":"1292_CR25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.1915","volume":"11","author":"R Gandhi","year":"2010","unstructured":"Gandhi R, Kumar D, Burns EJ, et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol. 2010;11:846\u201353.","journal-title":"Nat Immunol"},{"key":"1292_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imr.12027","volume":"252","author":"S Rutz","year":"2013","unstructured":"Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev. 2013;252:116\u201332.","journal-title":"Immunol Rev"},{"key":"1292_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, et al. Innate lymphoid cells\u2014a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145\u20139.","journal-title":"Nat Rev Immunol"},{"key":"1292_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","volume":"43","author":"MS Denison","year":"2003","unstructured":"Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 2003;43:309\u201334.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1292_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747\u201385.","journal-title":"Annu Rev Immunol"},{"key":"1292_CR30","doi-asserted-by":"publisher","first-page":"14381","DOI":"10.3390\/molecules181114381","volume":"18","author":"YR Chiang","year":"2013","unstructured":"Chiang YR, Li A, Leu YL, et al. An in vitro study of the antimicrobial effects of indigo naturalis prepared from Strobilanthes formosanus Moore. Molecules. 2013;18:14381\u201396.","journal-title":"Molecules"},{"key":"1292_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13020-015-0061-x","volume":"10","author":"HT Xiao","year":"2015","unstructured":"Xiao HT, Peng J, Hu DD, et al. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice. Chin Med. 2015;10:29.","journal-title":"Chin Med"},{"key":"1292_CR32","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1158\/1078-0432.CCR-11-0431","volume":"17","author":"Y Li","year":"2011","unstructured":"Li Y, Ligr M, McCarron JP, et al. Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion. Clin Cancer Res. 2011;17:4414\u201324.","journal-title":"Clin Cancer Res"},{"key":"1292_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","volume":"20","author":"W Strober","year":"2002","unstructured":"Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495\u2013549.","journal-title":"Annu Rev Immunol"},{"key":"1292_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/icb.2010.35","volume":"88","author":"T Takamura","year":"2010","unstructured":"Takamura T, Harama D, Matsuoka S, et al. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol. 2010;88:685\u20139.","journal-title":"Immunol Cell Biol"},{"key":"1292_CR35","doi-asserted-by":"crossref","unstructured":"Kociba RJ, Schwetz BA. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Drug Metab Rev. 1982;13:387\u2013406.","DOI":"10.3109\/03602538209029986"},{"key":"1292_CR36","first-page":"w13592","volume":"142","author":"C Pot","year":"2012","unstructured":"Pot C. Aryl hydrocarbon receptor controls regulatory CD4+\u00a0T cell function. Swiss Med Wkly. 2012;142:w13592.","journal-title":"Swiss Med Wkly"},{"key":"1292_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","volume":"212","author":"MG Roncarolo","year":"2006","unstructured":"Roncarolo MG, Gregori S, Battaglia M, et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28\u201350.","journal-title":"Immunol Rev"},{"key":"1292_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux H, O\u2019Garra A, Bigler M, et al. A CD4+\u00a0T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737\u201342.","journal-title":"Nature"},{"key":"1292_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ni.1912","volume":"11","author":"L Apetoh","year":"2010","unstructured":"Apetoh L, Quintana FJ, Pot C, et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010;11:854\u201361.","journal-title":"Nat Immunol"},{"key":"1292_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","volume":"21","author":"ID Mascanfroni","year":"2015","unstructured":"Mascanfroni ID, Takenaka MC, Yeste A, et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat Med. 2015;21:638\u201346.","journal-title":"Nat Med"},{"key":"1292_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"J Qiu","year":"2012","unstructured":"Qiu J, Heller JJ, Guo X, et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity. 2012;36:92\u2013104.","journal-title":"Immunity"},{"key":"1292_CR42","doi-asserted-by":"publisher","first-page":"e0128335","DOI":"10.1371\/journal.pone.0128335","volume":"10","author":"S Wagage","year":"2015","unstructured":"Wagage S, Harms Pritchard G, Dawson L, et al. The group 3 innate lymphoid cell defect in aryl hydrocarbon receptor deficient mice is associated with T cell hyperactivation during intestinal infection. PLoS One. 2015;10:e0128335.","journal-title":"PLoS One"},{"key":"1292_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cyto.2014.09.007","volume":"74","author":"E Nikoopour","year":"2015","unstructured":"Nikoopour E, Bellemore SM, Singh B. IL-22, cell regeneration and autoimmunity. Cytokine. 2015;74:35\u201342.","journal-title":"Cytokine"},{"key":"1292_CR44","first-page":"534","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K, Ogawa A, Mizoguchi E, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534\u201344.","journal-title":"J Clin Invest"},{"key":"1292_CR45","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s10620-015-3632-x","volume":"60","author":"T Ji","year":"2015","unstructured":"Ji T, Xu C, Sun L, et al. Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of DSS-induced colitis. Dig Dis Sci. 2015;60:1958\u201366.","journal-title":"Dig Dis Sci"},{"key":"1292_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00535-015-1064-1","volume":"50","author":"D Sheehan","year":"2015","unstructured":"Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50:495\u2013507.","journal-title":"J Gastroenterol"},{"key":"1292_CR47","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/ecco-jcc\/jjw010","volume":"10","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Ma T, Chen W, et al. MicroRNA-124 promotes intestinal inflammation by targeting aryl hydrocarbon receptor in Crohn\u2019s disease. J Crohns Colitis. 2016;10:703\u201312.","journal-title":"J Crohns Colitis"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1292-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1292-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1292-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:37:49Z","timestamp":1589449069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1292-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1292-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]},"assertion":[{"value":"21 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}